Latest debt-to-equity ratio
Supernus Pharmaceuticals Debt-to-equity ratio
Direct answer
Supernus Pharmaceuticals's debt-to-equity ratio is 3.9%.
The verified market snapshot reports 3.9%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 20, 2026.
Get free Supernus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 3.9%
Explore related company data
View Supernus Pharmaceuticals's market capitalizationView Supernus Pharmaceuticals's price-to-book ratioView Supernus Pharmaceuticals's return on equityView Supernus Pharmaceuticals's dividend yieldView Supernus Pharmaceuticals's 52-week price rangeView Supernus Pharmaceuticals's revenue growthView Supernus Pharmaceuticals's profit marginView all Supernus Pharmaceuticals key metricsReturn to Supernus Pharmaceuticals profile